Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production

详细信息    查看全文

• 作者：Wei Yang^aAuthor Vitae ; Sijun Liu^bAuthor Vitae ; Tao Bai^aAuthor Vitae ; Andrew J. Keefe^aAuthor Vitae ; Lei Zhang^aAuthor Vitae ; Jean-Rene Ella-Menye^aAuthor Vitae ; Yuting Li^aAuthor Vitae ; Shaoyi Jiang^a ; ^b ; ^{sjiang@uw.edu" class="auth_mail}Author Vitae
• 关键词：Nanomaterials ; Free antibody production ; Long-circulating ; Polymers
• 刊名：Nano Today
• 出版年：February, 2014
• 年：2014
• 卷：9
• 期：1
• 页码：10-16
• 全文大小：1398 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Poly(ethylene glycol) (PEG) has been incorporated into nanoparticles (NPs) to improve circulation time from systemic circulation for decades with limited success. Recent studies have shown that PEG induces the production of PEG-specific antibodies after repeated injections. Here, we demonstrate zwitterionic poly(carboxybetaine) (PCB)-based nanomaterials with no production of polymer-specific antibodies, while PEG-coated NPs generated PEG-specific antibodies. Furthermore, PCB-coated NPs exhibited prolonged circulation time and showed little change between the first and second doses (t_1/2 = 55.8 and 55.6 h), with no accelerated blood clearance suffered by PEG-coated NPs (t_1/2 drops from 8.7 to 5.2 h). These findings are significant advances toward solving the long-standing clinical challenge of developing nanomaterials that are able to resist both immune response and immediate bodily clearance.